Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan‐cancer survey of epithelial–mesenchymal transition markers across the Cancer Genome Atlas

10 Jan 2017

Abstract excerpt

BACKGROUND: While epithelial-mesenchymal transition (EMT) can be readily induced experimentally in cancer cells, the EMT process as manifested in human tumors needs to be better understood. Pan-cancer genomic datasets from The Cancer Genome Atlas (TCGA), representing over 10,000 patients and 32 distinct cancer types, provide a rich resource for examining correlative patterns involving EMT mediators in the setting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Single-cell and spatial transcriptomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28073171
DOI: 10.1002/dvdy.24485

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan‐cancer survey of epithelial–mesenchymal transition markers across the Cancer Genome AtlasPMID 28073171Read ↗

EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signaturesSemantic proximity Read ↗

The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy responseSemantic proximity Read ↗

A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.Semantic proximity Read ↗

Integrative Transcriptomic Analysis Reveals a Multiphasic Epithelial–Mesenchymal Spectrum in Cancer and Non-tumorigenic CellsSemantic proximity Read ↗

A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer.Semantic proximity Read ↗

Pan-sarcoma characterization of lncRNAs in the crosstalk of EMT and tumor immunity identifies distinct clinical outcomes and potential implications for immunotherapySemantic proximity Read ↗

Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases.Semantic proximity Read ↗

Epithelial-Mesenchymal Transformation Related Genomic Analysis Reveals Prognostic And Immunogenic Significance In Colorectal CancerSemantic proximity Read ↗

Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer.Semantic proximity Read ↗

Factors Determining Epithelial-Mesenchymal Transition in Cancer ProgressionSemantic proximity Read ↗

Mass Cytometric and Transcriptomic Profiling of Epithelial-Mesenchymal Transitions in Human Mammary Cell LinesSemantic proximity Read ↗

Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.